Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Pediatric Diabetes|October 3, 2008
Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girlLuigi Tarani, Francesco Costantino, Gundula Notheis, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|May 20, 2010
Addison's disease and severe encephalopathy in an infant with HIV infectionSkadi Beblo, Johannes Allmendinger, Roland Pfäffle, et al.The Journal of Allergy and Clinical Immunology|December 25, 2007
Dysregulation of innate immune receptors on neutrophils in chronic granulomatous diseaseDominik Hartl, Natalie Lehmann, Florian Hoffmann, et al.Mycoses|September 12, 2006
Posaconazole for treatment of refractory invasive fungal diseaseG Notheis, L Tarani, F Costantino, et al.Nature Communications|February 5, 2022
A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorderJulian C Lui, Adalbert Raimann, Hironori Hojo, et al.European Journal of Immunology|January 20, 2007
Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasmaMichael Humbert, Sascha Antoni, Boris Brill, et al.Mycoses|June 1, 2011
Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary casesJan Däbritz, Andishe Attarbaschi, Kathrin Tintelnot, et al.AIDS (London, England)|July 11, 2008
Response to combination antiretroviral therapy: variation by age, Caroline A Sabin, Colette J Smith, et al.Blood|February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment optionsMichael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.HIV Medicine|November 3, 2009
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection, Steve Welch, Mike Sharland, et al.Pageof 3